@thehappylungsproject

thehappylungsproject has been a member of Linktree for 2 years and joined in June 2024. The social media accounts linked to from thehappylungsproject are: • Facebook • Instagram Besides social media accounts, thehappylungsproject has populated their site with: • Looking Ahead: The Future of Diagnostic Testing for Patients - The Happy Lungs Project • ASCO 2026: RET Cancer Highlights • Community Advisory Board - The Happy Lungs Project • RET Fusion vs. RET Mutation: What are They and What is the Difference? • RET Inhibitor Plus Chemotherapy For RET Lung Cancer Patients • How Susan Wojcicki Helped Spark a National Lung Cancer Genetics Study • ctDNA and Liquid Biopsy in RET-Positive Lung Cancer • RET-Fusion Positive NSCLC: Why Genomic Testing Matters for Your Treatment • Carrie Griffin - Lung Cancer Survivor Story • Moderna's mRNA Cancer Vaccines in NSCLC • April Vokes - Lung Cancer Survivor Story • Meet our new Executive Director! • 2026 RET Research Webinar - The Happy Lungs Project • 2026 RET Webinar: Meet Our Speakers • Mickey Harris - Lung Cancer Survivor Story • ASCO 2026: Selpercatinib Shows Strong Results in Early-Stage RET+ Lung Cancer • RET Cancer Research Takes Center Stage at ASCO, May 2026 • GAVRETO Clinical Trial Results & Hope for RET+ Lung Cancer • Submit Your Question - The Happy Lungs Project • Steps to Take After a RET-Positive Lung Cancer Diagnosis • RETgistry: Advancing Care for RET-Altered Cancers • Q&A from the 2025 RET Lung Cancer Annual Webinar • Funded RET Lung Cancer Research - The Happy Lungs Project • The Role of Biomarker Testing in Early stage NSCLC • Finding the Right RET Oncologist for Your Cancer Treatment • Positive results for selpercatinib for early stage-RET lung cancer • Discover biomarker insights on happylungsproject.org • 2025 RET Cancer Research Update • 2025 RET Webinar: Meet Our Speakers • POISE study at Massachusetts General Hospital • 2025 RET Research Update Webinar - The Happy Lungs Project • Current RET Clinical Trials - The Happy Lungs Project • RET Cancer Highlights - 2025 IASLC • Announcing the Lung Cancer Genetics Study Database • Navigating The Lung Cancer Clinical Trial Enrollment Process • Home Health Care: Bringing Cancer Care Home • Enhancing the Quality of Life for Lung Cancer Patients • Ellipses’ RET inhibitor EP0031 advances to Phase 2 clinical trials • RET Highlights - 2025 American Society of Clinical Oncology • RET Highlights - 2025 American Association for Cancer Research (AACR) • Cancer Cell Lines: Consider Donating to Advance Research • A Legacy of Hope in the Fight Against Lung Cancer • Lung Cancer Genetics Study • March Newsletter • Stronger Together: Our RET-Positive Lung Cancer Partners • Breaking Ground: Successful Treatment Options for RET-Positive Lung Cancer • Susan: A Legacy of Hope in the Fight Against Lung Cancer • Donate to fund RET-Positive Lung Cancer Research + Treatments • Boosting Research: The Role of Lung Cancer Registries for RET-Positive Lung Cancer Patients • Lung Cancer Survivor Stories: RET-Positive Stories of Hope • A Letter from Ilana to a Recently Diagnosed RET Patient • Submit a Question • RSVP for the 2024 RET Research Update - The Happy Lungs Project • Ethical Considerations in RET Lung Cancer Clinical Trials • What to Ask Your Doctor When Diagnosed with RET-Positive Lung Cancer • Cracking the Code: New Lung Cancer Vaccines • RET Lung Cancer Patient Registries • What RET Gene Alteration Means for Your Lung Cancer • Livestrong Guidebook and Planner • Sign up for our newsletter! • Submit Your Questions • Understanding the Role of a Care Team in Treatment Planning • Finding the Right Time to Ask About Biomarker Testing • The 4 Stages of Non-Small Cell Lung Cancer (NSCLC) • RET Lung Cancer Clinical Trial Phases • Getting a Second Opinion for Your Lung Cancer Diagnosis • How Does RET-Positive Non-Small Cell Lung Cancer Spread • On the Passing of Susan Wojcick • Why Lung Cancer Biomarker Testing Matters for RET-Positive Patients • A Potential New Test for Lung Cancer: The E-Nose • International Lung Cancer Survivorship Conference (ILCSC) • Understanding RET-positive lung cancer's Impact on Non-Smokers • Enhance Wellbeing & Relieve Pain with Oncology Acupuncture • Our Path Forward • Current RET Clinical Trials • Why Participate in Clinical Trials? • The Happy Lungs Project Update (July 2024) • Immunotherapy and RET Lung Cancer • Scientific Advisory Board • Resistance: When RET Lung Cancer Treatments Stop Working • Latest Research from ASCO Annual Meeting • Current Treatment Options for RET Lung Cancer • Looking Ahead: The Future of Diagnostic Testing for Patients